Goldman Sachs Group Inc Rani Therapeutics Holdings, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.03 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$715,6960.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$650,3130.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$438,9770.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$422,5020.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $35.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...